Company intelligence
DIA
Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world
About DIA
DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
Verified activity
Signals from DIA
7 published signals
Presence & Recognition
DIA hosted the DIA-MHRA Global Summit in London from November 16-17, 2026, to tackle medicines and healthcare products regulatory science.
Reported by DIA
Presence & Recognition
DIA announced that program and session abstracts for the 11th DIA Cell and Gene Therapy Products Symposium in Japan are now available.
Reported by DIA
Presence & Recognition
DIA announced that nominations for the DIA Inspire Awards are open until 15 September.
Reported by DIA
Presence & Recognition
DIA announced the inaugural DIA-MHRA Global Summit will take place in London from November 16-17, 2026, featuring Daniel O'Connor and Magda Papadaki as founding program committee members.
Reported by DIA
Products & Services
DIA launched a new course with Swissmedic covering understanding ICH E6(R3) Annex 2 for evolving clinical trial designs.
Reported by DIA
Presence & Recognition
DIA hosted a free QPPV Talks webinar on September 3, 2026, featuring Benjamin Keserue and Karin Kempe discussing the different faces of the QPPV role across consultancy, big pharma, and smaller companies.
Reported by DIA
Presence & Recognition
DIA Singapore Annual Meeting 2026 will feature senior regulatory leaders and international authorities sharing perspectives on collaboration, convergence, and new regulatory approaches to support innovation and patient access.
Reported by DIA